Pharmaceutical formulation for regulating the timed release of biologically active compounds based on a polymer matrix

摘要

A formulation containing a biologically active compound having a structure with hydrogen bonding sites is blended with a polymer having a structure with complementary hydrogen bonding sites, the polymer forming hydrolytic degradation products that promote the release of the biologically active compound from the polymer.